[Skip to Content]
[Skip to Content Landing]
September 1977

β-Endorphin-Induced Changes in Schizophrenic and Depressed Patients

Author Affiliations

From the Rockland Research Institute (Drs Kline and Cooper), Orangeburg, NY, the Department of Medicine (Dr Kline), Lenox Hill Hospital, New York, the Hormone Research Laboratory (Dr Li), University of California, San Francisco, the Department of Psychiatry (Dr Lehmann), McGill University, Montreal, the Research Institute for Neurochemistry (Dr Lajtha), Rockland Research Institute, Ward's Island, NY, and the Bronx Psychiatric Center (Dr Laski), Bronx, NY.

Arch Gen Psychiatry. 1977;34(9):1111-1113. doi:10.1001/archpsyc.1977.01770210125012

Recent and exciting research in animals has described endogenous polypeptides, endorphins, which in many biological respects resemble opiate agonists.1-3 While behavioral effects in animals are under intense investigation, the effects of the pure endorphins in man require specific testing. The effect of opiate antagonists in schizophrenic patients4 are in some dispute, but a recent doubleblind study revealed no effects.5 Thus, direct measures of injected endorphins are relevant to understanding their effects in man. Accordingly, when the opportunity presented itself, it seemed logical to evaluate synthetic β-endorphin in schizophrenic and depressed patients, and this preliminary report describes our initial observations. Thirty milligrams of synthetic material was prepared by one of us (C. H. L.) and made available for this purpose; subsequently, a second batch was used.6

SUBJECTS AND METHODS Laboratory Procedures  Preliminary experiments were carried out to determine whether or not morphine-like substances in blood could

First Page Preview View Large
First page PDF preview
First page PDF preview